2021
DOI: 10.1111/pde.14652
|View full text |Cite
|
Sign up to set email alerts
|

Blastic plasmacytoid dendritic cell neoplasm with cutaneous presentation: A case series in children

Abstract: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive hematologic malignancy that can present with multiorgan involvement including the skin. While this entity accounts for 0.1% of all cutaneous lymphomas in adults, fewer than 90 pediatric cases have been described in the literature. We present three cases of pediatric BPDCN, highlighting the variable cutaneous and clinical presentation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…BPDCN is a rare and clinically aggressive hematologic malignancy derived from pDC precursors, which normally accumulate in lymph nodes in response to antigens from viral infections or autoimmune diseases 1 . Although it most commonly presents in males older than 65 years, it has been very rarely described in pediatric populations 2 . Approximately 50%–66% of patients with BPDCN exhibit genetic abnormalities, including loss of tumor suppressor genes and mutations characteristic of myelodysplastic syndrome 3 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…BPDCN is a rare and clinically aggressive hematologic malignancy derived from pDC precursors, which normally accumulate in lymph nodes in response to antigens from viral infections or autoimmune diseases 1 . Although it most commonly presents in males older than 65 years, it has been very rarely described in pediatric populations 2 . Approximately 50%–66% of patients with BPDCN exhibit genetic abnormalities, including loss of tumor suppressor genes and mutations characteristic of myelodysplastic syndrome 3 .…”
Section: Discussionmentioning
confidence: 99%
“…1 Although it most commonly presents in males older than 65 years, it has been very rarely described in pediatric populations. 2 Approximately 50%-66% of patients with BPDCN exhibit genetic abnormalities, including loss of tumor suppressor genes and mutations characteristic of myelodysplastic syndrome. 3 Developmental ontogeny studies suggest that the initial malignant transformation seen in pDCs may start in the skin prior to dissemination to the bone marrow.…”
Section: Discussionmentioning
confidence: 99%